Nyce, Jonathan W.2019-11-112019-11-112002-10-31International Publication # WO2002085297A2http://hdl.handle.net/10342/7542A composition comprises as the active agent a Non-glucocorticoid steroid, analogue thereof, a ubiquinone, or their salts, in an amount effective for reducing levels of, or hypersensitivity to, adenosine, increasing levels of lung surfactant or ubiquinone, or for preventing or treating respiratory, lung and cancer diseases. The present treatment is useful for treating asthma, rhinitis, COPD, CF, RDS, pulmonary fibrosis, cancer and other diseases.en-USbreathingasthmaallergiesPatent